ALMED Medicrea International SA Class O

Medicrea Announces Financial Calendar For 2017

LYON, France & NEW YORK--(BUSINESS WIRE)--

The MEDICREA Group (Alternext Paris: FR0004178572 - ALMED), worldwide leader pioneering the development and manufacture of personalized analytical services and implant solutions for the treatment of complex spinal conditions, announces its financial calendar for the year ending December 31st 2017. Publications will be submitted after market. This calendar is provided for information only and may be subject to change

2017 FINANCIAL CALENDAR
 
▪   2016 Annual Sales     January 12th, 2017
▪ 2016 Annual Results March 29th, 2017
▪ 2017 First Quarter Sales April 13th, 2017
▪ Annual General Meeting June 15th, 2017
▪ 2017 Half Year Sales July 11th, 2017
▪ 2017 Half Year Results October 5th, 2017
▪ 2017 Third Quarter Sales October 12th, 2017
▪ 2017 Annual Sales January 11th, 2018
 

About MEDICREA (www.medicrea.com)

MEDICREA specializes in bringing pre-operative digital planning and pre and post-operative analytical services to the world of complex spine. Through the lens of predictive medicine, MEDICREA leads the design, integrated manufacture, and distribution of 30+ FDA approved implant technologies, utilized in over 100k spinal surgeries to date. Operating in a $10 billion marketplace, MEDICREA is an SME with 160 employees worldwide, which includes 55 at its USA Corp. subsidiary in NYC. The Company has an ultra-modern manufacturing facility in Lyon, France housing the development and production of 3D-printed titanium patient-specific implants.

By leveraging its proprietary software analysis tools with big data and deep learning technologies supported by an expansive collection of clinical and scientific data, MEDICREA is well-placed to streamline the efficiency of spinal care, reducing procedural complications and limiting time spent in the O.R.

For further information, please visit: medicrea.com.

Connect with MEDICREA:

FACEBOOK | INSTAGRAM | TWITTER | WEBSITE | YOUTUBE

MEDICREA is listed on ALTERNEXT Paris

ISIN: FR 0004178572 – Ticker: ALMED

EN
11/01/2017

Underlying

ALMEDMedicrea International SA Class O

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Medicrea International SA Class O

 PRESS RELEASE
Free
ALMED Medicrea Intern...

MEDICREA Reports Third Quarter 2020 Sales

LYON, France & NEW YORK--(BUSINESS WIRE)-- The MEDICREA® Group (Euronext Growth Paris: FR0004178572 – ALMED ; OTCQX Best Market –MRNTF), pioneering the transformation of spinal surgery through Artificial Intelligence, predictive modeling and patient specific implants with its UNiD™ ASI (Adaptive Spine Intelligence) proprietary software platform, services and technologies, publishes sales for the third quarter of 2020. (€ millions) YTD September 2019 YTD September 2020 Variation USA Rest of the world Total Sales Including Q3 13.7 10.6 24.3 8.2 12.6 8.7 21....

October 8, 2020 1 EN
 PRESS RELEASE
Free
ALMED Medicrea Intern...

MEDICREA Reports First Half 2020 Results

LYON, France & NEW YORK--(BUSINESS WIRE)-- The MEDICREA® Group (Euronext Growth Paris: FR0004178572 – ALMED ; OTCQX Best Market –MRNTF), pioneering the transformation of spinal surgery through Artificial Intelligence, predictive modeling and patient specific implants with its UNiD™ ASI (Adaptive Spine Intelligence) proprietary software platform, services and technologies, reports its unaudited results for the first half of 2020, as approved by the Board of Directors on August 28, 2020. €’million Q1 2020 Q2 2020 H1 2020 H1 2019 Sales Gross margin in % of sales EBITDA (1...

September 4, 2020 1 EN
 PRESS RELEASE
Free
ALMED Medicrea Intern...

MEDICREA Announces the Appointment of an Independent Expert

LYON, France & NEW YORK--(BUSINESS WIRE)-- The MEDICREA® Group (Euronext Growth Paris: FR0004178572 – ALMED ; OTCQX Best Market –MRNTF), pioneering the transformation of spinal surgery through Artificial Intelligence, predictive modeling and patient specific implants with its UNiD™ ASI (Adaptive Spine Intelligence) proprietary software platform, services and technologies, announces the appointment of an independent expert. Following the announcement of the voluntary and friendly cash tender offer for the shares of Medicrea International (Euronext Growth Paris: FR0004178572 - ALMED, PEA-PME e...

August 3, 2020 1 EN
 PRESS RELEASE
Free
ALMED Medicrea Intern...

Medtronic to Acquire Medicrea

DUBLIN & LYON, France--(BUSINESS WIRE)-- Medtronic plc (NYSE:MDT), a global leader in medical technology, and Medicrea (Euronext Growth Paris: FR0004178572 – ALMED Medicrea; OTCQX Best Market – MRNTF), a pioneer in the transformation of spinal surgery through artificial intelligence, predictive modeling and patient specific implants, today announced that they have entered into a tender offer agreement for the acquisition of all outstanding shares of Medicrea. The friendly voluntary all-cash tender offer will be at a price of €7.00 per Medicrea share (the “Tender Offer”). The Boards of Director...

July 15, 2020 1 EN
 PRESS RELEASE
Free
ALMED Medicrea Intern...

MEDICREA Reports First Half 2020 Sales

LYON, France & NEW YORK--(BUSINESS WIRE)-- The MEDICREA® Group (Euronext Growth Paris: FR0004178572 – ALMED ; OTCQX Best Market –MRNTF), pioneering the transformation of spinal surgery through Artificial Intelligence, predictive modeling and patient specific implants with its UNiD™ ASI (Adaptive Spine Intelligence) proprietary software platform, services and technologies, publishes sales for the first half of 2020. (€ millions) H1 2019 H1 2020 Variation Variation at Constant Exchange Rate USA Rest of the world Total Sales 8.7 7.4 16.1 7.6 5.6 13.2 -13%...

July 9, 2020 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch